Found 8 matching trials
Research Study Comparing Different Tablets With the Study Medicine Semaglutide in Healthy Men PHASE1 This study looks at different tablets with a new study medicine called sema...
Show More Location
Novo Nordisk Investigational Site
Learn More & Join Trial
BALANCE-OBS: Bofanglutide (GZR18) Versus Semaglutide in Latin American Adults With Overweight or Obesity PHASE3 The goal of this clinical trial is to evaluate the efficacy and safety of B...
Show More Location
Centro de Investigación Clínica y Medicina Traslacional (CIMeT)
Learn More & Join Trial
A Clinical Trial Investigating the Comparison of Three Different Concentrations of NN9535 in Healthy Male Subjects PHASE1 This trial is conducted in Europe. The aim of this clinical trial is to inv...
Show More Location
Multiple Locations
Learn More & Join Trial
A Clinical Trial Comparing Semaglutide in Healthy People Who Eat and Take the Medicine at Different Times PHASE1 The goal of this trial is to find out whether taking semaglutide tablets at...
Show More Location
Novo Nordisk Investigational Site
Learn More & Join Trial
New Triple Therapy in Newly Diagnosed Type 2 Diabetes PHASE3 The goal of this clinical trial is to learn the efficany of combination the...
Show More Location
The First Affiliated Hospital of Sun Yat-sen University
Learn More & Join Trial
SHAPE-ENDO: Pilot Randomized Trial of Multimodal Pre-Surgical Optimization Versus Standard Surgery in Patients With Obesity and Early-Stage Endometrial Cancer PHASE4 SHAPE-ENDO is a single-center, open-label, pilot randomized clinical trial ...
Show More Location
Multiple Locations
Learn More & Join Trial
Research Study Comparing New Tablets of Semaglutide in New Doses, in Healthy People PHASE1 In this study a known investigational medicinal product called semaglutide ...
Show More Location
Novo Nordisk Investigational Site
Learn More & Join Trial
A Research Study Comparing Blood Levels of Medicines NNC0194-0499 and Semaglutide Administered as a Combination Formulation Versus Two Separate Formulations PHASE1 Novo Nordisk is developing a combination of 2 medicines (NNC0194-0499 and s...
Show More Location
Altasciences Company Inc.
Learn More & Join Trial